SHREYAL PATEL: Open Payments
NPI 1992381198 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,082 in 141 payments from 21 companies in 2025. Trend: 2023 $2,645 · 2024 $2,834 · 2025 $3,082
Food & beverage: $3,002Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $508 |
| Janssen Biotech, Inc. | 27 | $446 |
| GENZYME CORPORATION | 13 | $368 |
| UCB, Inc. | 13 | $336 |
| Novartis Pharmaceuticals Corporation | 13 | $271 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $178 |
| Kerecis Limited | 1 | $155 |
| Lilly USA, LLC | 7 | $146 |
| Regeneron Healthcare Solutions, Inc. | 5 | $133 |
| Botanix SB Inc | 8 | $131 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, RINVOQ, ILUMYA, Kerecis SurgiClose, TALTZ.
Industry payments across FL — which companies pay providers there.
